Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

GlobeNewswire04-08

EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2425916289?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bqHNObAr8CrVwzrqvqcC2Q--~B/aD02NzY7dz0xOTE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5208759a733ea80ac9000f786835c59f","is_english":true,"pubTime":"2024-04-08 20:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2425916289","market":"us","top_or_hot":-1,"title":"Gritstone bio to Participate in Upcoming Investor and Scientific Conferences","media":"GlobeNewswire","content":"<div>\n<p>EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gritstone-bio-participate-upcoming-investor-120000682.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gritstone bio to Participate in Upcoming Investor and Scientific Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGritstone bio to Participate in Upcoming Investor and Scientific Conferences\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-08 20:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/gritstone-bio-participate-upcoming-investor-120000682.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gritstone-bio-participate-upcoming-investor-120000682.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://finance.yahoo.com/news/gritstone-bio-participate-upcoming-investor-120000682.html","article_id":"2425916289","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bqHNObAr8CrVwzrqvqcC2Q--~B/aD02NzY7dz0xOTE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5208759a733ea80ac9000f786835c59f"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2425916289","pubTimestamp":1712577600,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"23rd Annual Needham Virtual Healthcare Conference Date and Time:Tuesday, April 9, 2024at11:00am ETLocation:Virtual. Canaccord Genuity Horizons in Oncology Virtual Conference Panel Title: Cancer Vaccines – Building on Recent LearningsDate and Time:Monday, April 15, 2024at11:00am ETLocation:Virtual. Cambridge Healthtech Institute’s Immuno-Oncology Summit Europe Presentation Title: Clinical Trial Results with a Personalised Neoantigen Vaccine in a Cold Tumour—Can We Bring the Heat?Date and Time:Wednesday, April 24, 2024at9:05am BSTLocation:London, UK","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4568":"美国抗疫概念","GRTS":"Gritstone Oncology Inc."},"translate_title":"Gritstone bio将参加即将举行的投资者和科学会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRTS":0.9},"content_text":"EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor and scientific conferences. Select events (marked by *) will be webcasted live and webcast details will be available on the ‘Events’ page of Gritstone bio’s website: https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for 30 days following each event.\n23rd Annual Needham Virtual Healthcare Conference (Presentation*)Date and Time: Tuesday, April 9, 2024 at 11:00am ETLocation: Virtual\nCanaccord Genuity Horizons in Oncology Virtual Conference (Panel)Panel Title: Cancer Vaccines – Building on Recent LearningsDate and Time: Monday, April 15, 2024 at 11:00am ETLocation: Virtual\nCambridge Healthtech Institute’s Immuno-Oncology Summit Europe (Presentation)Presentation Title: Clinical Trial Results with a Personalised Neoantigen Vaccine in a Cold Tumour—Can We Bring the Heat?Date and Time: Wednesday, April 24, 2024 at 9:05am BSTLocation: London, UK\n7th International Neoantigen Summit (Presentation)Panel Title: Clinical Trial Data with a Personalised Neoantigen Cancer Vaccine in MetastaticColorectal CancerPanel Date and Time: Tuesday, April 30, 2024 at 12:30pm CESTLocation: Amsterdam, Netherlands\nPEGS BOSTON (Panel)Panel Title: Personalized Cancer Vaccines - Where are They Going Now?Date and Time: Monday, May 13, 2024 at 9:00am ETLocation: Boston, MA\nCitizens JMP Life Sciences Conference (Fireside Chat*)Date and Time: Tuesday, May 14, 2024 at 10:30am ETLocation: New York, NY\nAbout Gritstone bioGritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease. www.gritstonebio.com\nGritstone ContactsInvestors:George E. MacDougallGritstone bio, Inc.ir@gritstone.com\nMedia:Dan Budwick1AB(973) 271-6085dan@1abmedia.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2425916289"}